Journal article
Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation
N Worel, BE Shaw, M Aljurf, M Koh, A Seber, D Weisdorf, J Schwartz, S Galeano, Y Kodera, PW Eldridge, S Hashmi, Y Atsuta, J Szer, W Saber, D Niederwieser, HT Greinix
Transplantation and Cellular Therapy | ELSEVIER SCIENCE INC | Published : 2021
Abstract
SARS-CoV-2 has spread rapidly worldwide, but the full impact of the COVID-19 pandemic on the field of hematopoietic cell transplantation (HCT) remains unknown. To understand this better, an 18-item online survey was disseminated by the Worldwide Network for Blood & Marrow Transplantation with questions exploring SARS-CoV-2 testing algorithms, mobilization, and cryopreservation strategies and COVID-19 infections in allogeneic related and autologous hematopoietic progenitor cell (HPC) donors. The aim of this survey was to assess the impact of the outbreak on policies relating to HPC mobilization, collection, and processing with respect to changes in daily routine. A total of 91 individual resp..
View full abstract